Harvard Apparatus Regenerative Technology Inc.
HRGN
$2.18
-$0.17-7.40%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 414.00K | 226.00K | 219.00K | 123.00K | 317.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 414.00K | 226.00K | 219.00K | 123.00K | 317.00K |
| Cost of Revenue | 391.00K | 206.00K | 199.00K | 112.00K | 302.00K |
| Gross Profit | 23.00K | 20.00K | 20.00K | 11.00K | 15.00K |
| SG&A Expenses | 778.00K | 1.09M | 1.03M | 1.08M | 1.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.11M | 1.83M | 1.92M | 1.84M | 2.15M |
| Operating Income | -1.69M | -1.61M | -1.70M | -1.71M | -1.83M |
| Income Before Tax | -1.70M | -1.60M | -1.69M | -1.70M | -1.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.70M | -1.60M | -1.69M | -1.70M | -1.82M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.70M | -1.60M | -1.69M | -1.70M | -1.82M |
| EBIT | -1.69M | -1.61M | -1.70M | -1.71M | -1.83M |
| EBITDA | -1.69M | -1.61M | -1.70M | -1.71M | -1.83M |
| EPS Basic | -0.10 | -0.09 | -0.10 | -0.10 | -0.11 |
| Normalized Basic EPS | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 |
| EPS Diluted | -0.10 | -0.09 | -0.10 | -0.10 | -0.11 |
| Normalized Diluted EPS | -0.06 | -0.06 | -0.06 | -0.06 | -0.07 |
| Average Basic Shares Outstanding | 17.58M | 17.58M | 17.19M | 17.03M | 15.92M |
| Average Diluted Shares Outstanding | 17.58M | 17.58M | 17.19M | 17.03M | 15.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |